Circulating beta-hydroxybutyrate levels in advanced HFrEF: the determinants and prognostic impact

Back

ESC Professional Premium Access

Circulating beta-hydroxybutyrate levels in advanced HFrEF: the determinants and prognostic impact

Session: Outcomes in heart failure

Topic: Peripheral Circulation, Metabolism, Skeletal Muscle

Speaker: Doctor V. Melenovsky (Prague, CZ)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Vojtech Melenovsky

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

0 follower

6 more presentations in this session

Impact of patient characteristics on heart failure and cardiomyopathy onset related to pregnancy from 1997 to 2019. Swedish nationwide register-based study.

Speaker: Doctor C. Basic (Gothenburg, SE)

Educational level and risk of all-cause death in patients with heart failure with reduced ejection fraction (HFrEF): a report from the WARCEF Trial

Speaker: Doctor B. Corica (Modena, IT)

Impact of left atrial dysfunction on mortality in patients with atrial fibrillation and heart failure

Speaker: Doctor J. Yamamoto (Tokyo, JP)

Echocardiography-based risk score predicts cardiovascular outcomes in ischemic heart failure patients with reduced ejection fraction

Speaker: Doctor K. Hu (Wuerzburg, DE)

Anemia and 1-year outcomes in hospitalized patients with heart failure with preserved ejection fraction: Findings from the China Cardiovascular Association Database-Heart Failure Center Registry

Speaker: Doctor A. Cai (Guangzhou, CN)

Access the full session

Outcomes in heart failure

Speakers: Doctor V. Melenovsky, Doctor C. Basic, Doctor B. Corica, Doctor J. Yamamoto, Doctor K. Hu...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources